Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

November’s top stories: Boehringer’s two new clinical trials for Pradaxa

Sanofi and Regeneron report promising results from Phase III rheumatoid arthritis study, while Boehringer plans to initiate two new clinical trials for Pradaxa. Drugdevelopment-technology.com wraps up the key headlines from November 2013.

Go Top